The world of medicine is beginning to increasingly acknowledge the potential of expressive arts therapies such as art, music, drama, dance/movement, poetry/creative writing and play in the context of healing, treatment, psychotherapy, counselling and rehabilitation. Activities such as drawing, drumming, creative movement and play acting allow individuals of all ages to express deep-seated thoughts and feelings, improve physical, mental and emotional well-being and boost self-esteem and…

Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Changed
06/Sep/2014
Condition